Cipher Pharmaceuticals Inc (id:13749 CPH)
14.86 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 9:04:28 AM)
Exchange closed, opens in 2 days
About Cipher Pharmaceuticals Inc
Market Capitalization 371.05M
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
Headquarters (address) |
5750 Explorer Drive Mississauga L4W 0A9 ON Canada |
Phone | 905 602 5840 |
Website | https://www.cipherpharma.com |
Employees | 0 |
Sector | Healthcare |
Industry | Drug Manufacturers Specialty & Generic |
Ticker | CPH |
Exchange | Toronto Stock Exchange |
Currency | CAD |
52 week range | 5.35 - 19.69 |
Market Capitalization | 371.05M |
P/E trailing | 16.29 |
P/E forward | 12.72 |
Price/Sale | 14.02 |
Price/Book | 3.75 |
Beta | 1.17 |
EPS | 0.890 |
EPS Canada (ID:82, base:722) | 1.84 |